> CPDR Issued U.S. Patents
U.S. Patent
No. 7,537,896 - Androgen-regulated PMEPA1 gene and polypeptides
Complete
Document
U.S. Patent
No. 6,828,429 - Prostate-Specific Gene, PCGEM1, and the Methods
of Using PCGEM1 to Detect, Treat, and Prevent Prostate Cancer
Complete
Document
U.S. Patent No. 6,566,130 - Androgen-Regulated
Gene Expressed in Prostate Tissue
Complete
Document
> Published U.S. Patent Applications:
Methods of diagnosing or treating prostate cancer using the erg gene, alone or in combination with other over or under expressed genes in prostate cancer
Complete
Document
Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations
Complete
Document
Androgen-Regulated PMEPA1 Gene and Polypeptides
Complete
Document
Prostate-Specific Gene, PCGEM1, and Methods
of Using PCGEM1 to Detect, Treat, and Prevent Prostate Cancer
Complete
Document
Method of Detecting Androgen-Regulated Gene
Complete
Document
Enhanced Diagnostic Potential of Prostate-Specific
Antigen Expressing Cells
Complete
Document
> Published PCT Applications
Prostate Cancer-Specific Alterations in ERG Gene Expression and Detection and Treatment Methods Based on Those
Complete
Document
Prostate-Specific Gene, PCGEM1, and Methods
of Using PCGEM1 to Detect, Treat, and Prevent Prostate Cancer
Complete
Document
Enhanced Diagnostic Potential of Prostate-Specific
Antigen Expressing Cells*
Complete
Document
Androgen-Regulated
PMEPA1 and Cancer
Complete
Document
